Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

JCO precision oncology·2026
Same author

A digital twin framework for adaptive treatment planning in radiotherapy.

Physics in medicine and biology·2026
Same author

Four-dimensional on-beam computed tomography reconstruction using projection-difference images.

Physics in medicine and biology·2026
Same author

Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Modeling variable interactions using Bayesian networks to identify direct predictors of radiation-induced optic neuropathy after proton therapy: implications for personalized toxicity risk stratification.

Physics in medicine and biology·2026
Same author

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: May 21, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

12.9K

Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy.

Keyur D Shah1,2, Beow Y Yeap1, Hoyeon Lee1

  • 1Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

JCO Clinical Cancer Informatics
|March 19, 2025
PubMed
Summary

A new model predicts rectal toxicity in prostate cancer patients undergoing radiotherapy. This tool aids personalized treatment selection by integrating dosimetric and non-dosimetric factors for both photon and proton therapy.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

196
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K

Related Experiment Videos

Last Updated: May 21, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

12.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

196
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Oncology

Background:

  • Acute rectal toxicity is a common side effect of radiotherapy for prostate cancer.
  • Personalized treatment selection is crucial to minimize toxicity while maintaining efficacy.
  • Current predictive models may not fully capture complex dosimetric factors across different radiation modalities.

Purpose of the Study:

  • To develop and validate a predictive model for acute rectal toxicity in prostate cancer patients treated with photon and proton radiotherapy.
  • To integrate dosimetric and non-dosimetric variables for improved prediction accuracy.
  • To aid in personalized treatment selection for radiotherapy.

Main Methods:

  • A prospective multi-institutional cohort of 278 patients was analyzed.
  • A convolutional neural network (CNN) was developed to analyze dose-area histograms (DAHs) and integrate with non-dosimetric predictors.
  • Model performance was compared against logistic regression (LR) using the area under the curve (AUC).

Main Results:

  • Key predictors included rectum length, race, age, and hydrogel spacer use.
  • The CNN model achieved an AUC of 0.81 in the validation set, outperforming LR (AUC = 0.54).
  • The model showed high sensitivity and specificity in photon and proton therapy subsets, indicating strong predictive capability.

Conclusions:

  • A novel approach effectively predicts rectal toxicity in prostate cancer patients undergoing radiotherapy with photons and protons.
  • Integrating dosimetric features from DAHs using CNNs with non-dosimetric factors enhances predictive accuracy.
  • The model shows potential for guiding treatment decisions and warrants prospective validation.